Clin2
NCT07088250Possibly a fitRecruiting

Statins for Treating Brain Bleeding

Cerebrovascular DisordersIntracranial HemorrhagesIntracranial HemorrhageIntracerebral Haemorrhage

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
264 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have been diagnosed with a brain bleed (intracerebral hemorrhage) seen on a CT scan.
  • You are between 18 and 80 years old.
  • The bleed is in the upper part of your brain (not the lower part or brainstem).
  • Your symptoms started between 3 and 24 hours ago, and you can start the study drug within 48 hours.
  • You are conscious enough to have a Glasgow Coma Scale score of 9 or higher.
  • Your bleed is between 5 and 35 milliliters in size (about the size of a small egg to a large walnut).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07243704Recruiting· Phase 3
Antiplatelet medicine to prevent heart events after brain bleed

This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.

Guntur, Andhra Pradesh
NCT05589454Not yet recruiting· Phase 4
Comparing doses of cholesterol medicine for stroke with brain microbleeds

This trial tests whether a more intensive dose of a common cholesterol medicine (atorvastatin) increases or decreases the risk of bleeding in the brain for people who have had a stroke and also have tiny brain bleeds. It aims to find the safest and most effective way to use statins in this situation.

Chongqing, Chongqing Municipality
NCT03936361Recruiting· Phase 3
Statins after a stroke bleed in the brain (Phase 3)

This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.

Boston, Massachusetts
NCT03753555Recruiting· Phase 4
High-intensity statin treatment for certain stroke artery plaque cases

This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.

Shenyang
NCT06358313Recruiting· Phase 3
Clopidogrel with statins for small vessel stroke

This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.

Kafr ash Shaykh
NCT07344610Recruiting
Short-term high-dose statin therapy after stroke

This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.

Shenyang, Liaoning

Hear when a new Cerebrovascular Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.